QuestionAugust 17, 2025

A patient with impaired fasting glucose is at risk of developing type II diabetes. Which medication might the NP consider prescribing to reduce the patient's risk of progressing to diabetes? Biguanides, such as metformin (Glucophage) Secretagogues, such as glipizide (Glucotrol) Insulin, such as insulin glargine (Lantus) Thiazolidinediones, such as pioglitazone (Actos) Sulfonylureas, such as glyburide (Diabeta)

A patient with impaired fasting glucose is at risk of developing type II diabetes. Which medication might the NP consider prescribing to reduce the patient's risk of progressing to diabetes? Biguanides, such as metformin (Glucophage) Secretagogues, such as glipizide (Glucotrol) Insulin, such as insulin glargine (Lantus) Thiazolidinediones, such as pioglitazone (Actos) Sulfonylureas, such as glyburide (Diabeta)
A patient with impaired fasting glucose is at risk of developing type II diabetes. Which
medication might the NP consider prescribing to reduce the patient's risk of progressing to
diabetes?
Biguanides, such as metformin (Glucophage)
Secretagogues, such as glipizide (Glucotrol)
Insulin, such as insulin glargine (Lantus)
Thiazolidinediones, such as pioglitazone (Actos)
Sulfonylureas, such as glyburide (Diabeta)

Solution
4.3(245 votes)

Answer

Biguanides, such as metformin (Glucophage) Explanation 1. Identify the medication class Biguanides, specifically metformin, are known to reduce the risk of progression from impaired fasting glucose to type II diabetes.

Explanation

1. Identify the medication class<br /> Biguanides, specifically metformin, are known to reduce the risk of progression from impaired fasting glucose to type II diabetes.
Click to rate:

Similar Questions